Pancreatic Cancer Research

ResearcherColumbia UniversityNo recent work listed

Kostas Syrigos

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5109951064. Sources: OpenAlex.

Their work

Papers
19 (first author 13, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
16
Papers, trials and grants by year

2011: 5 papers · 2012: 6 papers · 2013: 4 papers · 2014: 3 papers · 2015: none · 2016: 1 paper

Papers 19

  1. The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy. Co-author DOI 10.1080/14737140.2016.1192471↗
  2. Maintenance therapy with capecitabine in patients with locally advanced unresectable pancreatic adenocarcinoma. Last author DOI 10.3892/ol.2014.2238↗
  3. First line treatment for metastatic pancreatic adenocarcinoma: looking for the step forward. Co-author DOI 10.6092/1590-8577/2622↗
  4. Elderly patients with pancreatic cancer. First author DOI 10.6092/1590-8577/2682↗
  5. Pancreatic cancer: what about screening and detection? First author DOI 10.6092/1590-8577/1645↗
  6. New therapeutic strategies in the second line setting of advanced or metastatic pancreatic adenocarcinoma. First author DOI 10.6092/1590-8577/1650↗
  7. Novel agents and future prospects in the treatment of pancreatic adenocarcinoma. First author DOI 10.6092/1590-8577/1654↗
  8. Pharmacogenomics in pancreatic adenocarcinoma: new data and their clinical implications. First author DOI 10.6092/1590-8577/1662↗
  9. Use of supportive care for symptom management in pancreatic cancer: application of clinical research to patient care. Co-author DOI 10.6092/1590-8577/939↗
  10. Clinical and laboratory biomarkers in the management of pancreatic adenocarcinoma. First author DOI 10.6092/1590-8577/943↗
  11. Novel agents and new combination treatments on phase I studies on solid tumors and pancreatic cancer. First author DOI 10.6092/1590-8577/947↗
  12. Clinical studies in the second line setting of advanced pancreatic cancer: are we making any progress? Co-author DOI 10.6092/1590-8577/948↗
  13. Novel agents in early phase clinical studies on refractory pancreatic cancer. First author DOI 10.6092/1590-8577/714↗
  14. Translational research. New findings and potential future applications in pancreatic adenocarcinoma. First author DOI 10.6092/1590-8577/712↗
  15. A benefit-risk assessment of erlotinib in non-small-cell lung cancer and pancreatic cancer. First author DOI 10.2165/11586540-000000000-00000↗
  16. Rationale for inhibition of the hedgehog pathway paracrine loop in pancreatic adenocarcinoma. First author DOI 10.6092/1590-8577/3375↗
  17. Novel agents for the treatment of pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. Co-author PMID 21737890↗
  18. Updates on first-line treatment of metastatic pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. First author PMID 21737891↗
  19. Updates on treatment of gemcitabine-refractory pancreatic adenocarcinoma. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011. First author PMID 21737894↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Muhammad Wasif Saif · 18 shared papers, 2011–2016 · strength 0.97
  2. Alexios S Strimpakos · 7 shared papers, 2011–2013 · strength 0.35
  3. Vasilis Stefanos Ramfidis · 2 shared papers, 2013–2014 · strength 0.12
  4. Dimitra Grapsa · 1 shared paper, 2016 · strength 0.08
  5. Frank Charles Passero · 1 shared paper, 2016 · strength 0.08
  6. Andromachi Kougioumtzopoulou · 1 shared paper, 2014 · strength 0.07
  7. Evangelos Sarris · 1 shared paper, 2013 · strength 0.06
  8. Froso Konstantinou · 1 shared paper, 2013 · strength 0.06
  9. Giannis Mountzios · 1 shared paper, 2011 · strength 0.06
  10. Kristin Kaley · 1 shared paper, 2014 · strength 0.05
  11. Vassilios Ramfidis · 1 shared paper, 2012 · strength 0.04
  12. Meropi Panagiotarakou · 1 shared paper, 2012 · strength 0.04
  13. Nektaria Makrilia · 1 shared paper, 2011 · strength 0.04
  14. Anastasios Dimou · 1 shared paper, 2011 · strength 0.04
  15. Eirini Merika · 1 shared paper, 2011 · strength 0.04
  16. Haiying Cheng · 1 shared paper, 2011 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.